Authors reply: Dual versus single long-acting bronchodilator use could raise acute coronary syndrome risk by over 50

J Intern Med. 2022 May;291(5):707-708. doi: 10.1111/joim.13439. Epub 2022 Jan 18.

Lianne Parkin^{1

2}, Sheila Williams¹, Katrina Sharples^{2

3

4}, David Barson^{1

2}, Simon Horsburgh^{1

2}, Rod Jackson⁵, Billy Wu⁶, Jack Dummer^{2

4}

¹ Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand.
² Pharmacoepidemiology Research Network, University of Otago, Dunedin, New Zealand.
³ Department of Mathematics and Statistics, University of Otago, Dunedin, New Zealand.
⁴ Department of Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand.
⁵ Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁶ Auckland Regional Public Health Service, Auckland, New Zealand.

No abstract available

Publication types